This study aimed to evaluate the expression of the selected stem cell markers CD24, CD44, CD133, and ALDH1A1 in rhabdomyosarcoma in children and to determine their prognostic significance in this disease. This evidence concerns the gene PROM1 and rhabdomyosarcoma.